Clicky

Entera Bio Ltd.(ENTX) News

Date Title
Mar 25 OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
Mar 24 12 Best Biotech Penny Stocks to Invest In
Mar 23 We Think Entera Bio (NASDAQ:ENTX) Can Afford To Drive Business Growth
Mar 20 Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
Mar 8 Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
Mar 4 Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
Dec 26 Entera Bio Announces Closing of Private Placement - Extends Cash Runway into 2025
Nov 29 Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform
Aug 11 Entera Bio Announces Q2 2023 Financial Results and Corporate Updates
Apr 26 Menopause Luminary, Dr. Steven R. Goldstein, Joins Entera’s Clinical and Scientific Advisory Board